Suzen Medicare Profile
Key Indicators
- Authorised Capital ₹ 40.00 Cr
- Paid Up Capital ₹ 29.76 Cr
- Company Age 10 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 60.00 Cr
- Revenue Growth %
- Ebitda
- Net Worth
- Total Assets -1.23%
About Suzen Medicare
Suzen Medicare Private Limited (SMPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 November 2014 and has a history of Ten years and two months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 40.00 Cr and a paid-up capital of Rs 29.76 Cr.
The company currently has active open charges totaling ₹60.00 Cr.
The Key Managerial Personnel (KMP) at Suzen Medicare Private Limited India is Pushkarini Gopishetti as COMPANY SECRETARY.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232TG2014PTC096481
-
Company No.
096481
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Nov 2014
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Suzen Medicare?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pushkarini Gopishetti | Company Secretary | 06-Sep-2023 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suresh Kotini
|
Director | 17-Oct-2016 | Current |
|
Sai Bekkera
|
Director | 06-Jan-2015 | Current |
|
Yadagiri Boda
|
Director | 02-Apr-2015 | Current |
|
Garima Agrawal
|
Director | 16-Mar-2016 | Current |
|
Sreenivas Patlolla
|
Director | 16-Mar-2016 | Current |
Financial Performance of Suzen Medicare.
Suzen Medicare Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Suzen Medicare?
In 2021, Suzen Medicare had a promoter holding of 90.96% and a public holding of 9.04%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹60.00 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 60.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Feb 2023 | State Bank Of India | ₹60.00 Cr | Open |
How Many Employees Work at Suzen Medicare?
Unlock and access historical data on people associated with Suzen Medicare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Suzen Medicare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Suzen Medicare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
